×
Todo
Imágenes
Maps
Noticias
astellas
takenaka corporation
astellas pharma
k channel
japan
dihydropyridine
pharma inc
pharma intelligence
alumni
president toichi
tokyo
fujisawa pharmaceutical
Compartir
Esta imagen puede estar sujeta a los derechos de autor.
Facebook
WhatsApp
X
Encontré esta imagen de
ISV_HWD
con Google Imágenes
Correo electrónico
Presiona para copiar el vínculo
Vínculo copiado
Esta imagen puede incluir contenido explícito. El desenfoque de SafeSearch está activado.
Administrar configuración
Ver imagen
Las imágenes pueden estar sujetas a derechos de autor.
Visitar
Compartir
Esta imagen puede incluir contenido explícito. El desenfoque de SafeSearch está activado.
Administrar configuración
Ver imagen
Las imágenes pueden estar sujetas a derechos de autor.
Esta imagen puede incluir contenido explícito. El desenfoque de SafeSearch está activado.
Administrar configuración
Ver imagen
Las imágenes pueden estar sujetas a derechos de autor.
Yamanouchi Pharmaceutical Co. President Toichi Takenaka (R) and ...
www.alamy.com
TOKYO, Japan - Yamanouchi Pharmaceutical Co. President Toichi ...
www.alamy.com
Toichi Takenaka - Director at Healios | The Org
theorg.com
Toichi Takenaka - Director at Healios | The Org
theorg.com
CJU - Legends in Urology
www.canjurol.com
Dr. Toichi Takenaka received Lifetime Achievement Award at Informa ...
www.gifu-pu.ac.jp
Researcher At Heart: Toichi Takenaka's Journey From 'Empty Lab ...
scrip.citeline.com
Japan's Biopharma Excellence Celebrated At Pharma Intelligence ...
scrip.citeline.com
Yamanouchi, Fujisawa to merge - The Japan Times
www.japantimes.co.jp
Dr. Toichi Takenaka received Lifetime Achievement Award at Informa ...
www.gifu-pu.ac.jp
Toichi Takenaka - Director at Healios | The Org
theorg.com
Takenaka Corporation - Wikipedia
en.wikipedia.org
Toichi Takenaka - Director at Healios | The Org
theorg.com
PDF) Cardiovascular effects of YM099, a novel K channel opener.
www.researchgate.net
Toichi Takenaka - Director at Healios | The Org
theorg.com
Toichi Takenaka - Director at Healios | The Org
theorg.com
Annual Report 2003 (pdf 2.0MB) - Astellas Pharma Inc.
www.yumpu.com
PDF) Effect of a new vasoconstrictor 1,4-dihydropyridine, YC-170 ...
www.researchgate.net
March 31, 2006 Astellas Pharma Inc. ASTELLAS SELLS ALL OUTSTANDING ...
www.astellas.com
Astellas Transfers Its Group Member Company FMS Co., Ltd. to Canon ...
www.astellas.com
Toichi Takenaka's research works | Tokyo University of Pharmacy ...
www.researchgate.net
In Pictures: Japan's Richest
www.forbes.com
Yamanouchi Pharmaceutical President Toichi Takenaka and Fujisawa ...
www.gettyimages.ae
News Release | TAKENAKA CORPORATION
www.takenaka.co.jp
Yamanouchi Pharmaceutical President Toichi Takenaka and Fujisawa ...
www.gettyimages.ae
Yamanouchi Pharmaceutical President Toichi Takenaka and Fujisawa ...
www.gettyimages.ae
PDF) Studies on in vivo hypotensive mechanism of LP-805, a new ...
www.researchgate.net
Toichi Takenaka - Director at Healios | The Org
theorg.com
Yamanouchi Pharmaceutical President Toichi Takenaka and Fujisawa ...
www.gettyimages.ae
Pharmacokinetics and Cardiovascular Effects of YM21095, a Novel ...
academic.oup.com
PDF) Stereoselectivity in YM-12617 for α-adrenoceptor subtypes in ...
www.researchgate.net
News release Ferring and Astellas enter a license agreement on ...
www.ferring.com
PDF) K channel opening effects of YM099 in isolated tissues.
www.researchgate.net
Yamanouchi Pharmaceutical President Toichi Takenaka and Fujisawa ...
www.gettyimages.ae
In Pictures: Japan's Richest
www.forbes.com
Toichi Takenaka - Director at Healios | The Org
theorg.com
Yamanouchi Pharmaceutical President Toichi Takenaka and Fujisawa ...
www.gettyimages.ae
PDF) Effect of chronic treatment with YM358, an angiotensin II ...
www.researchgate.net
Pharmacological and Pharmacokinetic Characteristics of YM435, a ...
onlinelibrary.wiley.com
PDF) Assessment of nipradilol and its isomers by radioligand ...
www.researchgate.net
Toichi Takenaka - Director at Healios | The Org
theorg.com
conflictgypsy Publisher Publications - Issuu
issuu.com
News Release | TAKENAKA CORPORATION
www.takenaka.co.jp
PDF) Pheochromocytoma (PHEO)-harboring New England Deaconess ...
www.researchgate.net
Toichi Takenaka's research works | Tokyo University of Pharmacy ...
www.researchgate.net
Tamsulosin (Harnal, Flomax, OMNIC) | SpringerLink
link.springer.com
Takenaka Corporation
www.archinform.net
54527-84-3 Nicardipine HCl AKSci C652
aksci.com
Toichi Takenaka - Director at Healios | The Org
theorg.com
News - Gifu Pharmaceutical University
www.gifu-pu.ac.jp
The Causes of Failure: Case Studies of Eight Failed Acquisitions ...
link.springer.com
Toichi Takenaka - Director at Healios | The Org
theorg.com
Yamanouchi Pharmaceutical President Toichi Takenaka and Fujisawa ...
www.gettyimages.ae
Japan's Biopharma Excellence Celebrated At Pharma Intelligence ...
scrip.citeline.com
Toichi Takenaka's research works | Tokyo University of Pharmacy ...
www.researchgate.net
Tamsulosin (Harnal, Flomax, OMNIC) | SpringerLink
link.springer.com
Thrombolytic Activity of a Novel Modified Tissue-Type Plasminogen ...
www.sciencedirect.com
Kanta Kawai won the Impressive Research Award at The 8th ...
www.gifu-pu.ac.jp
Collaborative Search for Microorganisms in Vietnam November 2 ...
www.astellas.com
In Pictures: Japan's Richest
www.forbes.com
Takenaka Corporation - Alchetron, The Free Social Encyclopedia
alchetron.com
In Pictures: Japan's Richest
www.forbes.com
9+ Joint Marketing Agreement Templates - PDF, Word, Apple Pages ...
www.template.net
Takenaka Corporation
www.archinform.net
OFFICIAL J3AZ]
www.yumpu.com
PDF) Astellas Drug Discovery Strategy: Focus on Oncology
www.researchgate.net
The role of extracellular Ca<Superscript>2+</Superscript ...
link.springer.com
Enhancement of Tissue-type Plasminogen Activator-induced ...
www.thieme-connect.com
Tamsulosin (Harnal, Flomax, OMNIC) | SpringerLink
link.springer.com
New perspective for the management of M&A process: a merger ...
www.emerald.com
Effect of oq-Adrenoceptor Antagonists on Urinary Bladder Function ...
www.sciencedirect.com
Meet the people shaping the future of IP | Managing Intellectual ...
www.managingip.com
Effect of the Potassium Channel Opener YM934 on the Contractile ...
www.auajournals.org
The Business Week In Pictures
www.forbes.com
Astellas' oncology development pipeline | Download Table
www.researchgate.net
April 25, 2011 Astellas Announces Changes of Representative ...
www.astellas.com
A novel aromatase inhibitor, YM511
www.researchgate.net
BILLIONAIRES 2001 - Forbes
www.yumpu.com
EP0034432B1 - Sulfamoyl-substituted phenethylamine derivatives ...
patents.google.com
Takenaka Corporation
www.archinform.net
New perspective for the management of M&A process: a merger ...
www.emerald.com
Tamsulosin (Harnal, Flomax, OMNIC) | SpringerLink
link.springer.com
Frontiers | Dysfunctional Immune Regulation in Autoimmune ...
www.frontiersin.org
The Causes of Failure: Case Studies of Eight Failed Acquisitions ...
link.springer.com
In Pictures: Japan's Richest
www.forbes.com
Member Introduction | Forum for Innovative Regenerative Medicine
firm.or.jp
Meet the people shaping the future of IP | Managing Intellectual ...
www.managingip.com
WO2005013947A2 - Means and methods for treating a disease which is ...
patents.google.com
Vasopressin increases vascular endothelial growth factor secretion ...
www.sciencedirect.com
The Causes of Failure: Case Studies of Eight Failed Acquisitions ...
link.springer.com
US20080152640A1 - Means and Methods For Treating a Disease Which ...
patents.google.com
In Pictures: Japan's Richest
www.forbes.com
Biomolecules | Free Full-Text | IL-38: A New Player in ...
www.mdpi.com
News Release | TAKENAKA CORPORATION
www.takenaka.co.jp
PDF) Inhibitory effects of angiotensin II-antagonists on ...
www.researchgate.net
PDF) Be All That You Can Be: Enhancing Human Performance1 | Daniel ...
www.academia.edu
THE 10 BEST Restaurants in Itami (Updated May 2024) - Tripadvisor
www.tripadvisor.com
New perspective for the management of M&A process: a merger ...
www.emerald.com
IID 2008 Sponsors - Society for Investigative Dermatology-SID
www.yumpu.com
WO2005013947A2 - Means and methods for treating a disease which is ...
patents.google.com